Stearylamine (SA) was utilized to develop cationic nanovesicles to orient the nanovesicles to the tumor externalized phosphatidylserine, while hyaluronic acid (HA) was used to develop CD-44 targeting nanovesicles. Here, CD44 is linked to neoplasm.